Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Radiologie (Heidelberg, Germany)|April 20, 2023
[Positron emission tomography in CUP syndrome]Manuel RöhrichPET Clinics|April 5, 2023
Fibroblast Activation Protein Inhibitor PET Imaging in Head and Neck CancerManuel RöhrichData in Brief|June 4, 2020
Dataset of voxelwise correlated signal values of ADC, rCBV and FAP-specific PET of 13 Glioblastoma patientsManuel Röhrich, Lisa Loi, Ralf Floca, et al.Clinical Nuclear Medicine|June 8, 2026
Nuclear Medicine Imaging in Tumor Diagnostics Using FAPI-PET/CT: A Case-based Perspective on Malignant Peripheral Nerve Sheath TumorStephanie Göller, Justus Kaufmann, Anna-Maria Spektor, et al.Neuroendocrinology|March 11, 2025
A Review for the Clinician: Classifications, Genetics, and Treatment for Neuroendocrine Neoplasms of the Thymus (Thymic Carcinoids)Matthias Lang, Chrysanthi Anamaterou, Isabelle Mohr, et al.Oncotarget|September 13, 2015
Inhibition of 13-cis retinoic acid-induced gene expression of reactive-resistance genes by thalidomide in glioblastoma tumours in vivoDusan Milanovic, Carsten Sticht, Manuel Röhrich, et al.Seminars in Nuclear Medicine|February 7, 2026
Can FAPI-PET imaging address unmet needs in nephro-urology?Kalyani Pandya, Alexandra Lazar, Leonor Lopes Serrano, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 6, 2024
Deescalated 225Ac-PSMA-617 Versus 177Lu/225Ac-PSMA-617 Cocktail Therapy: A Single-Center Retrospective Analysis of 233 PatientsHendrik Rathke, Erik Winter, Frank Bruchertseifer, et al.Cancers|April 3, 2021
Supplemental 18F-FDG-PET/CT for Detection of Malignant Transformation of IPMN-A Model-Based Cost-Effectiveness AnalysisFelix Bicu, Johann S Rink, Matthias F Froelich, et al.Cancers|November 11, 2022
Subclass Analysis of Malignant, Inflammatory and Degenerative Pathologies Based on Multiple Timepoint FAPI-PET Acquisitions Using FAPI-02, FAPI-46 and FAPI-74Frederik M Glatting, Jorge Hoppner, Hans-Ulrich Kauczor, et al.Pageof 5